Sapient Capital’s Bristol-Myers Squibb BMY Stock Holding History

Sapient Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.15M	Buy	37,372 +364	+1%	+$20.9K	0.03%	151
2026 Q1	$2.24M	Sell	37,008 -3,625	-9%	-$211K	0.03%	148
2025 Q4	$2.2M	Sell	40,633 -8,253	-17%	-$397K	0.03%	154
2025 Q3	$2.16M	Sell	48,886 -36	-0.1%	-$1.68K	0.03%	142
2025 Q2	$2.26M	Sell	48,922 -84	-0.2%	-$4.12K	0.04%	133
2025 Q1	$2.99M	Sell	49,006 -503	-1%	-$29.3K	0.06%	119
2024 Q4	$2.8M	Sell	49,509 -1,725	-3%	-$96.4K	0.05%	122
2024 Q3	$2.65M	Sell	51,234 -297	-0.6%	-$13.9K	0.05%	126
2024 Q2	$2.14M	Sell	51,531 -708	-1%	-$31.7K	0.04%	125
2024 Q1	$2.83M	Sell	52,239 -634	-1%	-$32.3K	0.06%	120
2023 Q4	$2.71M	Buy	+52,873	New	+$2.78M	0.07%	115

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Sapient Capital's BMY Position: Q2 2026 in Review

Sapient Capital increased its Bristol-Myers Squibb (BMY) stake by 0.98% in Q2 2026, buying an estimated $20.9K and bringing the position to 37,372 shares worth $2.15M. The position accounts for 0.03% of the portfolio, ranked #151.

Sapient Capital first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.99M in Q1 2025. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Sapient Capital held 37,372 shares of Bristol-Myers Squibb worth $2.15M as of Q2 2026.
Sapient Capital bought 364 Bristol-Myers Squibb shares in Q2 2026, an estimated $20.9K.
Bristol-Myers Squibb made up 0.03% of Sapient Capital's portfolio in Q2 2026, its #151 holding.
Sapient Capital first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
Sapient Capital's Bristol-Myers Squibb position peaked at $2.99M in Q1 2025.
878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.